IGM Biosciences Inc (IGMS) — Cash Flow Quality Index

Latest as of June 2025: -0.52x

IGM Biosciences Inc (IGMS) has a Cash Flow Quality Index of -0.52x as of June 2025. Operating cash flow of $-50.79 Million is below net income of $97.58 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore IGM Biosciences Inc (IGMS) investment intensity to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-0.52x

Operating CF / Net Income

Operating Cash Flow

$-50.79 Million

USD

Net Income

$97.58 Million

USD

Data as of

Jun 2025

Most recent filing

Annual Cash Flow Quality Index for IGM Biosciences Inc (None–None)

Year-by-year earnings quality comparison for IGM Biosciences Inc. For live market cap and the full company financial profile, see IGM Biosciences Inc (IGMS) total market value.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.